1-Methylxanthine

1-Methylxanthine

SCHEMBL27663813

CC(C)CO.Cn1c(=O)[nH]c2nc[nH]c2c1=O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 9/20 0.77
▸ ADORA2A P29274 6/20 0.77
▸ ADORA3 P0DMS8 7/20 0.56
▸ PDE4A P27815 6/20 0.56
▸ PDE4B Q07343 6/20 0.56
▸ PDE4C Q08493 6/20 0.56
▸ PDE4D Q08499 6/20 0.56
▸ CFTR P13569 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ PDE2A O00408 1/20 0.47
▸ PDE5A O76074 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ SCN1A P35498 1/20 0.47
▸ PDE6C P51160 1/20 0.47
▸ PDE1A P54750 1/20 0.47
▸ PDE1B Q01064 1/20 0.47
▸ PDE3B Q13370 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Methylxanthine SCHEMBL10996 0.88 ADORA2B (1.00) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL27529726 0.86 ADORA2B (0.96) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL28309011 0.86 ADORA2B (0.96) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL9682658 0.86 ADORA2B (0.96) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL28460409 0.84 ADORA2B (0.84) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL7270651 0.83 ADORA2B (0.77) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL17748264 0.79 ADORA2B (0.89) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL29001829 0.78 ADORA2B (0.79) ADORA2BADORA2AADORA3PDE4APDE4B
1-Methylxanthine SCHEMBL16859909 0.78 ADORA2B (0.79) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL59949 0.77 ADORA2B (0.72) ADORA2BADORA2AADORA3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1842339-A Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient RENOMEDIX INST INC (JP) 2006-10-04 — — CN disclosed
Send feedback